Venus Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411B01019
  • NSEID: VENUSREM
  • BSEID: 526953
INR
750.00
-2.9 (-0.39%)
BSENSE

Dec 05

BSE+NSE Vol: 36.22 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
652.89
601.45
555.51
600.18
548.12
341.46
321.89
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
652.89
601.45
555.51
600.18
548.12
341.46
321.89
Raw Material Cost
348.77
344.28
317.79
379.07
347.94
168.47
189.67
Purchase of Finished goods
25.04
13.07
5.16
4.43
0.00
0.00
0.00
(Increase) / Decrease In Stocks
4.81
-2.66
8.04
3.48
-7.15
5.86
-7.72
Employee Cost
80.49
71.50
61.33
56.18
46.02
46.02
42.10
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
-0.01
0.01
Selling and Distribution Expenses
125.24
115.66
103.17
94.91
107.54
80.33
65.31
Other Expenses
0.00
0.00
0.00
-0.00
-0.01
0.01
-0.00
Total Expenditure (Excl Depreciation)
584.35
541.85
495.49
538.07
494.34
300.68
289.37
Operating Profit (PBDIT) excl Other Income
68.54
59.60
60.02
62.11
53.78
40.78
32.52
Other Income
15.95
11.58
10.32
8.31
19.63
5.31
6.09
Operating Profit (PBDIT)
84.49
71.18
70.34
70.42
73.41
46.09
38.61
Interest
0.07
0.09
0.12
0.48
13.02
13.31
25.41
Exceptional Items
9.91
0.00
0.00
0.00
23.44
-8.81
-8.96
Gross Profit (PBDT)
94.33
71.09
70.22
69.94
83.83
23.97
4.24
Depreciation
22.51
26.45
32.30
33.53
35.28
32.01
33.98
Profit Before Tax
71.82
44.64
37.92
36.41
48.55
-8.03
-29.73
Tax
26.50
16.16
11.36
-4.32
-13.21
1.96
-1.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
45.32
28.48
26.56
40.73
61.77
-10.00
-28.58
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
45.32
28.48
26.56
40.73
61.77
-10.00
-28.58
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
45.32
28.48
26.56
40.73
61.77
-10.00
-28.58
Equity Capital
13.37
13.37
13.37
13.37
12.34
12.34
12.34
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
547.58
474.18
446.97
427.08
387.94
311.03
320.18
Earnings per share (EPS)
33.9
21.3
19.87
30.46
50.06
-8.1
-23.16
Diluted Earnings per share
33.9
21.31
19.88
30.86
50.04
-8.1
-23.15
Operating Profit Margin (Excl OI)
10.5%
9.91%
10.8%
10.35%
9.81%
11.94%
10.1%
Gross Profit Margin
14.45%
11.82%
12.64%
11.65%
15.29%
7.02%
1.32%
PAT Margin
6.94%
4.74%
4.78%
6.79%
11.27%
-2.93%
-8.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 8.55% vs 8.27% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 59.13% vs 7.23% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 15.00% vs -0.70% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -22.22% vs -25.00% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Venus Remedies With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
652.89
0
652.89
Other Operating Income
0.00
0.00
0.00
Total Operating income
652.89
0
652.89
Raw Material Cost
348.77
0
348.77
Purchase of Finished goods
25.04
0
25.04
(Increase) / Decrease In Stocks
4.81
0
4.81
Employee Cost
80.49
0
80.49
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
125.24
0
125.24
Other Expenses
0.00
0.00
0.00
Total Expenditure (Excl Depreciation)
584.35
0
584.35
Operating Profit (PBDIT) excl Other Income
68.54
0.00
68.54
Other Income
15.95
0
15.95
Operating Profit (PBDIT)
84.49
0
84.49
Interest
0.07
0
0.07
Exceptional Items
9.91
0
9.91
Gross Profit (PBDT)
94.33
0
94.33
Depreciation
22.51
0
22.51
Profit Before Tax
71.82
0
71.82
Tax
26.50
0
26.50
Provisions and contingencies
0.00
0
0.00
Profit After Tax
45.32
0
45.32
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
45.32
0
45.32
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
45.32
0
45.32
Equity Capital
13.37
0
13.37
Face Value
10.00
0
0.00
Reserves
547.58
0
547.58
Earnings per share (EPS)
33.90
0
33.90
Diluted Earnings per share
33.90
0
33.90
Operating Profit Margin (Excl OI)
10.50%
0%
0.00
10.50%
Gross Profit Margin
14.45%
0%
0.00
14.45%
PAT Margin
6.94%
0%
0.00
6.94%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 652.89 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.55% vs 8.27% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 45.32 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 59.13% vs 7.23% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 68.54 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.00% vs -0.70% in Mar 2024

Annual - Interest
Interest 0.07 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -22.22% vs -25.00% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.50%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024